Rocuronium Hospira 10 mg/ml Injektions-/infusionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

rocuronium hospira 10 mg/ml injektions-/infusionsvätska, lösning

pfizer ab - rokuroniumbromid - injektions-/infusionsvätska, lösning - 10 mg/ml - rokuroniumbromid 10 mg aktiv substans - rokuroniumbromid

Sotalol 2care4 160 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sotalol 2care4 160 mg tablett

2care4 aps - sotalolhydroklorid - tablett - 160 mg - sotalolhydroklorid 160 mg aktiv substans - sotalol

Sotalol Viatris 40 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sotalol viatris 40 mg tablett

viatris limited - sotalolhydroklorid - tablett - 40 mg - sotalolhydroklorid 40 mg aktiv substans - sotalol

Sotacor 80 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sotacor 80 mg tablett

cheplapharm arzneimittel gmbh - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans; laktosmonohydrat hjälpämne - sotalol

Sotalol Viatris 80 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sotalol viatris 80 mg tablett

viatris limited - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans - sotalol

Sotalol 2care4 80 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sotalol 2care4 80 mg tablett

2care4 aps - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans - sotalol

Aggrastat 250 mikrogram/ml Koncentrat till infusionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aggrastat 250 mikrogram/ml koncentrat till infusionsvätska, lösning

correvio - tirofibanhydrokloridmonohydrat - koncentrat till infusionsvätska, lösning - 250 mikrogram/ml - tirofibanhydrokloridmonohydrat 281 mikrog aktiv substans - tirofiban

Aggrastat 50 mikrogram/ml Infusionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aggrastat 50 mikrogram/ml infusionsvätska, lösning

correvio - tirofibanhydrokloridmonohydrat - infusionsvätska, lösning - 50 mikrogram/ml - tirofibanhydrokloridmonohydrat 56 mikrog aktiv substans - tirofiban

Sotalol Ebb 80 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sotalol ebb 80 mg tablett

ebb medical ab - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans

Dasatinib Accordpharma Europeiska unionen - svenska - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiska medel - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.